Date Added: 15/03/2017
Date Updated: 15/03/2017
Pembrolizumab (Keytruda) for locally advanced melanoma – adjuvant therapy
Specialties: Oncology & radiotherapy
Technology Type: Drugs
Stage of development: Investigational - phase III
Stage of EAA: Prioritised for assessment
High risk patients, post-complete resection.
Stage of disease
Stage IIIA, IIIB, IIIC.
Place in Treatment